LENZ Therapeutics, Inc. (LENZ)
1 Item 5.02 filing since 2026-10-28 · 1 with an open seat · roles: CEO. Nasdaq. Biological Products, (No Diagnostic Substances). State: CA.
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 85 | 2026-10-28 | Retirement announced | CEO | subscribers | Open | LENZ Therapeutics, Inc. (LENZ): CEO Evert Schimmelpennink to retire |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works